Stock Taper
SOPHiA GENETICS SA, founded in 2011 and based in Switzerland, provides the cloud-based SOPHiA DDM platform for analyzing multimodal healthcare data, used globally by hospitals, labs, and biopharma.

The SOPHiA DDM™ Platform is a cloud-based SaaS that uses AI to analyze genomic and multimodal data, supporting healthcare in oncology, rare diseases, and more, to enhance diagnostics, treatment, and drug development through a decentralized data-dr...
| Map | REGION | Q2-2023 | Q4-2023 |
|---|---|---|---|
![]() | Europe the Middle East and Africa | $10.78M | $33.17M ▲ |
![]() | North America | $2.49M | $8.24M ▲ |
![]() | Latin America | $937K | $3.05M ▲ |
![]() | Asia Pacific | $846K | $2.85M ▲ |
Overall rating: D+
| PEER | PRICE | |
|---|---|---|
AGL | $92.54 | COMPARE |
ANRO | $35.13 | COMPARE |
NRC | $21.85 | COMPARE |
LRMR | $4.01 | COMPARE |
SLP | $18.39 | COMPARE |
CLLS | $3.40 | COMPARE |
ACIU | $2.65 | COMPARE |
OPRX | $7.95 | COMPARE |